Medical Condition News

RSS

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity Pharmaceuticals, Inc. today announced the initiation of the randomized Phase 2 portion of the trial of IPI-926 in combination with gemcitabine in patients with previously untreated, metastatic, pancreatic cancer.

22 Feb 2011

Health Canada approves Orexo's Abstral to treat chronic cancer pain

Orexo AB today announces that ProStrakan's partner, Paladin Labs Inc. has been informed by Health Canada, the Canadian Government Department with responsibility for public health, that it has approved Abstral.

22 Feb 2011

KemPharm commences KP201 Phase 1 trial for pain

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers with KP201, its novel abuse deterrent prodrug of hydrocodone for pain. KP201 is a new chemical entity and is the most advanced opioid-based lead candidate in KemPharm's emerging pipeline.

22 Feb 2011

Autism could be detected earlier and easier: Study

Scientists at Boston may have found the beginnings of a non-invasive diagnostic test that can detect abnormal brain waves that suggest increased risk for autism – a debilitating neurological disorder in babies. This test would be safe, inexpensive, and easy to perform and could make it possible for at-risk kids to get help right away rather than having to wait until months or years later, which is now the case with the behavioral tests believe experts.

22 Feb 2011

Healthcare disparities seen in epilepsy patients with low socioeconomic status

A newly published report reveals patients with epilepsy and low socioeconomic status (SES) are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life. The study also indicates that low SES patients used the hospital emergency room more often and had more visits to a general practitioner than epileptic patients at higher socioeconomic levels. Full findings are now available in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

22 Feb 2011

New Harris Poll suggests that many doctors dont help obese patients to lose weight

A new Harris Poll suggests that many doctors are doing little or nothing to help their overweight patients to lose weight.

22 Feb 2011

Noninvasive test to evaluate risk of ASD in infants

A computational physicist and a cognitive neuroscientist at Children's Hospital Boston have come up with the beginnings of a noninvasive test to evaluate an infant's autism risk.

22 Feb 2011

Epilepsy patients with low SES more likely to have poor quality of life

A newly published report reveals patients with epilepsy and low socioeconomic status are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life.

22 Feb 2011

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

22 Feb 2011

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease - including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults -, have introduced these mutations into mice and successfully treated HCM in the lab.

22 Feb 2011

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin(r) program, currently under evaluation for the treatment of cancer.

22 Feb 2011

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

MedTrust Online and Avantra Biosciences announced today a novel collaboration to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences' revolutionary QPDx multiplex immunoassay system.

22 Feb 2011

Simple on-road tests can help determine safe driving after stroke

Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.

22 Feb 2011

Radiologists who interpret more mammograms can determine breast cancer effectively

Radiologists who interpret more mammograms and spend some time reading diagnostic mammograms do better at determining which suspicious breast lesions are cancer, according to a new report published online on February 22 and in print in the April issue of Radiology.

22 Feb 2011

Study: Poor park planning linked with young children spending more time in computers, e-games

What does it take to keep children active when they get home from school? It seems that what your neighborhood offers in terms of parks and playgrounds has a lot to do with it.

22 Feb 2011

New technique allows early identification of metastasis in women with breast cancer

A quarter of all women who suffer from breast cancer are at risk of metastasis - a recurrence of the cancer. In recent years, researchers at Lund University, Sweden, have developed a technique that can identify in advance which patients belong to this risk group.

22 Feb 2011

GORE PROPATEN Vascular Graft for hemodialysis access receives CE Mark approval

W. L. Gore & Associates announced the GORE PROPATEN Vascular Graft for hemodialysis access has received CE Mark. Arteriovenous Grafts are used to create a conduit for repeated blood access during hemodialysis, allowing blood to be withdrawn from the body and cleansed when a patient has End Stage Renal Disease, commonly referred to as kidney failure.

22 Feb 2011

Study: Early detection of hearing impairment may prevent chronic disease in middle-aged adults

Several factors may be associated with hearing impairment in middle-aged adults, including cardiovascular disease risks, being male and having a noisy job, according to a report published online first in the Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. The paper will be appear in the May print issue of the journal.

22 Feb 2011

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Fate Therapeutics, Inc. presented encouraging preliminary data from an ongoing Phase 1b clinical trial of FT1050 at the 2011 BMT Tandem Meetings in Honolulu, Hawaii.

22 Feb 2011

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Sharing printed educational materials about the risk of squamous cell carcinoma with kidney transplant recipients appeared to be effective at increasing skin self-examination and encouraging follow-up with a dermatologist to determine risk of cancer, according to a report posted online today that will appear in the June issue of Archives of Dermatology, one of the JAMA/Archives journals.

22 Feb 2011

Medical Condition News

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Health Canada approves Orexo's Abstral to treat chronic cancer pain

KemPharm commences KP201 Phase 1 trial for pain

Autism could be detected earlier and easier: Study

Healthcare disparities seen in epilepsy patients with low socioeconomic status

New Harris Poll suggests that many doctors dont help obese patients to lose weight

Noninvasive test to evaluate risk of ASD in infants

Epilepsy patients with low SES more likely to have poor quality of life

FDA refuses Delcath's chemosaturation delivery system NDA filing

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

Simple on-road tests can help determine safe driving after stroke

Radiologists who interpret more mammograms can determine breast cancer effectively

Study: Poor park planning linked with young children spending more time in computers, e-games

New technique allows early identification of metastasis in women with breast cancer

GORE PROPATEN Vascular Graft for hemodialysis access receives CE Mark approval

Study: Early detection of hearing impairment may prevent chronic disease in middle-aged adults

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Educational intervention may increase awareness about kidney transplant recipients' risk of developing skin cancer

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Latest News